Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/26890
Title: EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases
Authors: tenBerge, J.
Hoffman, B. J.
Hawes, R. H.
van Enckevort, C.
Giovannini, M.
Erickson, R. A.
Catalano, M. F.
Fogel, R.
Mallery, S.
Faigel, D. O.
Ferrari, A. P.
Waxman, I
Palazzo, L.
Ben-Menachem, T.
Jowell, P. S.
McGrath, K. M.
Kowalski, T. E.
Nguyen, C. C.
Wassef, W. Y.
Yamao, K.
Chak, A.
Greenwald, B. D.
Woodward, T. A.
Vilmann, P.
Sabbagh, L.
Wallace, M. B.
Med Univ S Carolina
Inst J Paoli I Calmettes
Scott & White Mem Hosp & Clin
GI Consultants Ltd
Clin Caracas
Hennepin Cty Med Ctr
Portland Vet Adm Hosp
Universidade Federal de São Paulo (UNIFESP)
Univ Chicago
Univ Paris 07
Henry Ford Hosp
Duke Univ
Thomas Jefferson Univ Hosp
Mayo Clin
Univ Massachusetts
Aichi Canc Ctr Hosp
Univ Hosp Cleveland
Univ Maryland
Gentofte Univ Hosp
Clin Reina Sofia
Issue Date: 1-Jun-2002
Publisher: Mosby, Inc
Citation: Gastrointestinal Endoscopy. St Louis: Mosby, Inc, v. 55, n. 7, p. 859-862, 2002.
Abstract: Background.-The liver is a common site of metastases for various malignancies. EUS-guided fine needle aspiration (EUS-FNA) of liver masses has only been reported in small series from single centers. Methods: A retrospective questionnaire was sent by e-mail to 130 EUS-FNA centers around the world regarding indications, complications, and findings of EUS-FNA of the liver.Results: Twenty-one centers reported 167 cases of EUS-FNA of the liver. A complication was reported in 6 (4%) of 167 cases including the following: death in 1 patient with an occluding biliary stent and biliary sepsis, bleeding (1), fever (2), and pain (2). EUS-FNA diagnosed malignancy in 23 of 26 (89%) cases after nondiagnostic fine needle aspiration under transabdominal US guidance. EUS localized an unrecognized primary tumor in 17 of 33 (52%) cases in which CT had demonstrated only liver metastases. EUS image characteristics were not predictive of malignant versus benign lesions.Conclusion: EUS-guided FNA of the liver appears to be a safe procedure with a major complication rate of approximately 1%. EUS-FNA should be considered when a liver lesion is poorly accessible to US-, or CT-guided FNA should be considered when US- or CT-guided FNA fail to make a diagnosis, when a liver lesion(s) is detected (de novo) by EUS, and for investigation of possible upper GI primary tumors in the setting of liver metastases.
URI: http://repositorio.unifesp.br/handle/11600/26890
ISSN: 0016-5107
Other Identifiers: http://dx.doi.org/10.1067/mge.2002.124557
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.